ProQR Therapeutics (PRQR) Total Debt (2021 - 2024)
Historic Total Debt for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $4.9 million.
- ProQR Therapeutics' Total Debt rose 602.8% to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year increase of 602.8%. This contributed to the annual value of $5.0 million for FY2024, which is 681.8% up from last year.
- Latest data reveals that ProQR Therapeutics reported Total Debt of $4.9 million as of Q4 2024, which was up 602.8% from $4.6 million recorded in Q4 2023.
- ProQR Therapeutics' Total Debt's 5-year high stood at $50.4 million during Q4 2021, with a 5-year trough of $19910.1 in Q1 2021.
- Its 4-year average for Total Debt is $16.0 million, with a median of $4.9 million in 2024.
- Its Total Debt has fluctuated over the past 5 years, first soared by 21618109.17% in 2022, then crashed by 9034.26% in 2023.
- Over the past 4 years, ProQR Therapeutics' Total Debt (Quarter) stood at $50.4 million in 2021, then tumbled by 86.3% to $6.9 million in 2022, then crashed by 33.15% to $4.6 million in 2023, then increased by 6.03% to $4.9 million in 2024.
- Its last three reported values are $4.9 million in Q4 2024, $4.6 million for Q4 2023, and $3.1 million during Q3 2023.